The comparative in-vitro activity of eight newer quinolones and nalidixic acid.
about
In vitro activity of levofloxacin against a selected group of anaerobic bacteria isolated from skin and soft tissue infections.Increased activity of a new chlorofluoroquinolone, BAY y 3118, compared with activities of ciprofloxacin, sparfloxacin, and other antimicrobial agents against anaerobic bacteria.Comparative in vitro activity of PD 127,391, a new fluorinated 4-quinolone derivative.Mutation in the gyrA gene of quinolone-resistant clinical isolates of Acinetobacter baumanniiIn vitro activities of trovafloxacin against 557 strains of anaerobic bacteria.Comparative in vitro activities of sparfloxacin (CI-978; AT-4140) and other antimicrobial agents against staphylococci, enterococci, and respiratory tract pathogens.A-61827 (A-60969), a new fluoronaphthyridine with activity against both aerobic and anaerobic bacteria.Use of fluoroquinolone antimicrobial agents by cardiovascular and cardiopulmonary surgeonsIn vitro activities of three of the newer quinolones against anaerobic bacteria.In vitro activity of Bay y 3118, a new quinolone.In vitro activity of Bay Y3118 against anaerobic bacteriaEvaluation of the penetration of ciprofloxacin and amoxycillin into the bronchial mucosaQuinolones for the treatment of Neisseria gonorrhoeae and Chlamydia trachomatis.Respiratory and allergic disease. II. Chronic obstructive airways disease and respiratory infectionsComparative in vitro activity of a new fluorinated 4-quinolone, T-3262 (A-60969).Mechanisms of clinical resistance to fluoroquinolones in Enterococcus faecalis.
P2860
Q33693101-39FDC3C2-D19A-4849-8321-2B352FFE5481Q33755787-F703A3C7-8067-4890-B0B6-E2032E1EAEAFQ34685918-4F78631F-6AFF-4F49-B3E0-A7AB3DF4EF29Q35114895-B0828785-2E93-4B36-80FE-B7FB1362EAA9Q35127493-16EF610D-4B95-484E-B7D1-EF611F5E4ED6Q35283618-851742D9-80AB-4AE7-B127-F22FED8EFA44Q35288155-8D5E10EE-2862-4294-8D89-895E5E86D1FCQ35643095-7FF004CB-5EF8-4770-8C69-765F77E4E442Q35844319-6C8DEE64-8A7E-4598-8A8C-8C6FEE4A3B47Q35899898-103C9142-0243-4298-880A-7D3DB9C4DD2FQ35900446-DB7F494D-5DF7-460B-BEFC-7C4BEA862689Q36188204-765586B9-FEEE-428D-8408-6CEE47D4E044Q36624269-8A4147E5-2F0A-47AF-A54B-B550B92B5329Q36894089-F3A45E92-E84B-47FD-98AF-31C96F3A1FCBQ39818156-983B74D9-84DC-4629-8875-51A175F43564Q40284197-08D01D7E-593E-4BAB-8CD1-1885F90463D8
P2860
The comparative in-vitro activity of eight newer quinolones and nalidixic acid.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年学术文章
@wuu
1986年学术文章
@zh-cn
1986年学术文章
@zh-hans
1986年学术文章
@zh-my
1986年学术文章
@zh-sg
1986年學術文章
@yue
1986年學術文章
@zh
1986年學術文章
@zh-hant
name
The comparative in-vitro activity of eight newer quinolones and nalidixic acid.
@en
The comparative in-vitro activity of eight newer quinolones and nalidixic acid.
@nl
type
label
The comparative in-vitro activity of eight newer quinolones and nalidixic acid.
@en
The comparative in-vitro activity of eight newer quinolones and nalidixic acid.
@nl
prefLabel
The comparative in-vitro activity of eight newer quinolones and nalidixic acid.
@en
The comparative in-vitro activity of eight newer quinolones and nalidixic acid.
@nl
P1476
The comparative in-vitro activity of eight newer quinolones and nalidixic acid.
@en
P2093
P356
10.1093/JAC/18.SUPPLEMENT_D.1
P407
P478
18 Suppl D
P577
1986-11-01T00:00:00Z